What is TidalSense?
TidalSense is a venture-backed medical technology company specializing in AI-driven diagnostic and monitoring solutions for respiratory medicine. Founded in 2013, the company utilizes its patented N-Tidal sensor technology to provide unprecedented insights into lung physiology. By capturing high-accuracy, rapid-sampled CO2 data, TidalSense offers a diagnostic precision previously unseen in clinical settings. The company's market position is defined by its ability to bridge the gap between complex physiological data and actionable clinical intelligence, serving a critical need in the management of chronic and acute respiratory conditions.
How much funding has TidalSense raised?
TidalSense has raised a total of $28.3M across 2 funding rounds:
Other Financing Round
$9.3M
Unspecified
$19M
Other Financing Round (2023): $9.3M with participation from Downing Ventures and BGF
Unspecified (2026): $19M led by BGF, Airstream Capital, Cross-Border Impact Ventures, and Foresight Group Holdings
Key Investors in TidalSense
BGF
BGF is a prominent UK-based investment firm that provides growth capital to small and mid-sized businesses across various sectors, acting as a key partner for scaling enterprises.
Cross-Border Impact Ventures
An impact-focused venture capital firm that specializes in health technology, specifically targeting innovations that improve outcomes for women, children, and adolescents.
Airstream Capital
A specialized investment firm founded by industry executives that focuses on high-growth technology markets and management teams with significant potential for value creation.
What's next for TidalSense?
With this major enterprise-level funding, TidalSense is well-positioned to scale its operations and expand its footprint in the global health technology market. The strategic focus will likely center on deepening the clinical validation of its N-Tidal platform and navigating the regulatory pathways required for broader international adoption. As the company transitions into its next phase of growth, the integration of its AI-driven diagnostics into standard clinical workflows will be paramount. Investors are looking toward the firm to demonstrate sustained commercial traction and to solidify its role as a leader in the digital health and respiratory monitoring landscape.
See full TidalSense company page
